Rapid Micro Biosystems (RPID) Invested Capital (2020 - 2026)

Rapid Micro Biosystems' Invested Capital history runs 7 years deep, the most recent figure standing at $40.4 million for Q1 2026.

• In Q1 2026, Invested Capital fell 38.32% year-over-year to $40.4 million; the TTM figure through Mar 2026 stood at $40.4 million (down 38.32% YoY), while the FY2025 annual figure was $53.2 million, down 29.39% from the prior year.
• Invested Capital came in at $40.4 million for Q1 2026 at Rapid Micro Biosystems, down from $53.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $207.1 million in Q1 2022 to a low of $40.4 million in Q1 2026.
• A 5-year average of $113.0 million and a median of $105.9 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital soared 237.09% in 2022 and sank 42.33% in 2025, its largest moves.
• Rapid Micro Biosystems' Invested Capital stood at $164.2 million in 2022, then declined by 28.13% to $118.0 million in 2023, then tumbled by 36.14% to $75.4 million in 2024, then decreased by 29.39% to $53.2 million in 2025, then declined by 24.07% to $40.4 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $40.4 million, $53.2 million, and $64.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison